December 19, 2022
Boston Cell Standards Gains 510(k) Clearance for Breast Cancer Test Control Panels
Continue Reading
December 19, 2022
FDA clears Boston Cell Standards’ IHControls panel in breast cancer
Continue Reading
April 7, 2022
Study Establishes Boston Cell Standards’ Calibrated IHC Technology for Companion Diagnostic Immunohistochemistry
Continue Reading
April 4, 2022
Empowering Pathologists by Bringing Reference Standards to IHC
Continue Reading
March 11, 2022
Boston Cell Standards launches consortium for IHC testing
Continue Reading